Entero Healthcare Solutions Ltd Share Price Target From 2025 to 2030

Entero Healthcare Solutions Ltd is one of India’s emerging healthcare distribution platforms. With a growing presence across key Indian markets, the company has shown strong potential in the pharmaceutical supply chain industry. As of April 25, 2025, Entero Healthcare’s share is trading at ₹1,331.00 with a market capitalization of ₹5,780 crore. In this article, we’ll analyze Entero’s latest performance metrics, shareholding structure, and forecast its share price target from 2025 to 2030.

Current Performance Overview for Entero Healthcare Share Price

Here’s a detailed snapshot of Entero Healthcare’s market performance as of now:

• Open Price: ₹1,331.00

• Previous Close: ₹1,341.20

• Volume: 20,472 shares

• Value (Lacs): ₹272.07

• VWAP (Volume Weighted Average Price): ₹1,314.57

• Beta: 0.63

• Market Capitalization: ₹5,780 Crore

• Day High: ₹1,339.10

• Day Low: ₹1,294.20

• Upper Circuit Limit: ₹1,609.40

• Lower Circuit Limit: ₹1,073.00

• 52-Week High: ₹1,584.25

• 52-Week Low: ₹991.10

• Face Value: ₹10

• All-Time High: ₹1,584.25

• All-Time Low: ₹970.00

The current trading price of ₹1,331.00 places the stock closer to the lower end of its 52-week range, indicating room for upward movement. The low beta value of 0.63 reflects relatively low volatility, making it a safer investment option for conservative investors.

Shareholding Pattern for Entero Healthcare

Understanding the shareholding pattern helps in assessing the confidence level of various investor groups:

• Promoters: 52.42%

• Foreign Institutional Investors (FIIs): 19.92%

• Retail and Others: 18.02%

• Mutual Funds: 6.09%

• Other Domestic Institutions: 3.54%

A majority stake held by promoters indicates strong internal trust in the company's future growth. The 19.92% holding by FIIs and 6.09% by mutual funds suggests increasing institutional interest in the stock.

Entero Healthcare Share Price Target Forecast From 2025 To 2030

Based on current fundamentals, market performance, and sector outlook, here is the projected share price forecast for Entero Healthcare Solutions Ltd:

2025 Entero Healthcare Share Price Target: ₹1,331 – ₹1,609

In 2025, the share is likely to stay between ₹1,331 and its upper circuit limit of ₹1,609. Key growth drivers include:

• Strong distribution network expansion across India.

• Increasing demand for reliable pharmaceutical logistics.

• Stable market presence backed by promoter holding and low volatility.

2026 Entero Healthcare Share Price Target: ₹1,609 – ₹1,800

As Entero further strengthens its position in healthcare distribution, the share price may rise to ₹1,800 by 2026 due to:

• New partnerships with pharmaceutical brands.

• Technological integration in supply chain management.

• Growing market confidence led by institutional investments.

2027 Entero Healthcare Share Price Target: ₹1,800 – ₹2,050

By 2027, the stock could break past ₹2,000 as Entero gains further scale:

• Revenue growth from diversified service offerings.

• Deeper penetration into tier 2 and tier 3 cities.

• Rising brand trust in the pharma delivery ecosystem.

2028 Entero Healthcare Share Price Target: ₹2,050 – ₹2,300

In 2028, Entero may reach new highs supported by:

• Enhanced operational efficiency via automation.

• Stable cost structure leading to increased margins.

• Expansion into adjacent healthcare service verticals.

2029 Entero Healthcare Share Price Target: ₹2,300 – ₹2,600

With a broader presence across India and deeper institutional backing, the price target for 2029 lies between ₹2,300 and ₹2,600. Contributing factors include:

• Global expansion or JV announcements.

• Acquisition of regional distributors to consolidate market.

• Rising demand in B2B pharma distribution.

2030 Entero Healthcare Share Price Target: ₹2,600 – ₹3,000

By 2030, Entero Healthcare could evolve into a major player in India’s pharma logistics space. The share price may potentially touch ₹3,000 owing to:

• Industry leadership in healthcare distribution.

• Innovation-driven solutions in logistics and inventory management.

• Growing investor confidence and consistent financials.

Key Factors Driving Entero Healthcare’s Growth

Several industry and company-specific factors can boost Entero’s performance in the coming years:

• Healthcare Demand: Rising demand for medicines and diagnostics fuels the need for strong logistics providers.

• Regulatory Tailwinds: Government schemes like Ayushman Bharat expand pharmaceutical reach, benefiting distributors.

• Digital Integration: Adoption of AI and IoT for inventory and supply chain management enhances efficiency.

• Stable Promoter Confidence: With over 52% promoter holding, the company shows internal conviction for long-term success.

• Low Volatility: A beta of 0.63 suggests minimal speculative movement, suitable for long-term investors.

Risks and Challenges

Despite its potential, Entero faces certain risks:

• Regulatory Changes: Price caps or government policy shifts may impact revenue.

• High Competition: Both organized and unorganized players pose threats in regional markets.

• Execution Risks: Delays in expansion or tech integration can hinder growth targets.

• Economic Slowdowns: Any drop in healthcare spending could reduce order volumes temporarily.

FAQs

What is the projected Entero Healthcare share price in 2025?

The projected share price target for Entero Healthcare in 2025 ranges from ₹1,331 to ₹1,609, driven by distribution expansion and healthcare demand.

How does Entero’s shareholding pattern affect its stock performance?

With promoters holding over 52%, the company exhibits strong internal confidence, while FIIs and mutual funds reflect growing institutional interest, helping reduce retail-driven volatility.

Is Entero Healthcare a good investment?

Entero is well-positioned in a growing healthcare market with stable management, low volatility, and institutional backing, making it a potentially strong long-term investment.

Conclusion

Entero Healthcare Solutions Ltd is making solid strides in the healthcare logistics industry, backed by a robust distribution model, experienced management, and favorable macro trends. The share price targets for 2025 to 2030 reflect optimistic growth potential, making it a stock worth tracking closely. However, investors should keep an eye on regulatory policies and execution capabilities while making investment decisions.